(1)
Evaluation of Interleukin-35 in Patients With Type 2 Diabetes Mellitus and Its Association With Oxidative Stress and Metabolic Parameters. CAJMNS 2026, 7 (4), 234-241. https://doi.org/10.51699/cajmns.v7i4.3369.